These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 9248110)
1. Differences between male and female breast cancer. III. Prognostic features. Rudan I; Rudan N; Basić N; Basić V; Rudan D; Jambrisak Z Acta Med Croatica; 1997; 51(3):135-41. PubMed ID: 9248110 [TBL] [Abstract][Full Text] [Related]
2. Differences between male and female breast cancer. II. Clinicopathologic features. Rudan I; Rudan N; Basić N; Basić V; Rudan D Acta Med Croatica; 1997; 51(3):129-33. PubMed ID: 9248109 [TBL] [Abstract][Full Text] [Related]
3. Breast cancer prognosis. I. Prognostic factors in patients with node-negative (N0) breast cancer. Rudan I; Skorić T; Rudan N Acta Med Croatica; 1994; 48(4-5):159-63. PubMed ID: 7534517 [TBL] [Abstract][Full Text] [Related]
4. Breast cancer prognosis. II. Prognostic factors in patients with node-positive (N1-3) breast cancer. Rudan I; Skorić T; Rudan N Acta Med Croatica; 1994; 48(4-5):165-70. PubMed ID: 7534518 [TBL] [Abstract][Full Text] [Related]
5. Male breast cancer in the veterans affairs population: a comparative analysis. Nahleh ZA; Srikantiah R; Safa M; Jazieh AR; Muhleman A; Komrokji R Cancer; 2007 Apr; 109(8):1471-7. PubMed ID: 17342768 [TBL] [Abstract][Full Text] [Related]
6. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy. Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302 [TBL] [Abstract][Full Text] [Related]
7. Male breast cancer. Does the prognosis differ compared to female? Herman K; Lobaziewicz W; Skotnicki P; Fortuna J; Kusy T; Leśniak T Neoplasma; 2000; 47(3):191-5. PubMed ID: 11043845 [TBL] [Abstract][Full Text] [Related]
8. Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases. Wang-Rodriguez J; Cross K; Gallagher S; Djahanban M; Armstrong JM; Wiedner N; Shapiro DH Mod Pathol; 2002 Aug; 15(8):853-61. PubMed ID: 12181271 [TBL] [Abstract][Full Text] [Related]
9. [Clinical analysis of resectable breast cancer: a report of 6 263 cases]. Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535 [TBL] [Abstract][Full Text] [Related]
10. [Breast cancer: prognostic value of flow cytometry and hormone receptors. Apropos of a Lebanese series of patients]. Aftimos G; Trak-Smayra V; Moacdieh-Rehayel L J Med Liban; 2000; 48(1):8-17. PubMed ID: 10881437 [TBL] [Abstract][Full Text] [Related]
11. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion]. Zhao WH; Xu BH; Zhang P; Li Q; Zhao LM; Sun Y Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):137-40. PubMed ID: 17645853 [TBL] [Abstract][Full Text] [Related]
12. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer. Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899 [TBL] [Abstract][Full Text] [Related]
13. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Sarli L; Bader G; Iusco D; Salvemini C; Mauro DD; Mazzeo A; Regina G; Roncoroni L Eur J Cancer; 2005 Jan; 41(2):272-9. PubMed ID: 15661553 [TBL] [Abstract][Full Text] [Related]
14. Breast cancer prognosis. III. Prognostic factors in patients with distant metastases (M1) at the time of diagnosis. Rudan I; Skorić T; Rudan N Acta Med Croatica; 1994; 48(4-5):171-4. PubMed ID: 7534519 [TBL] [Abstract][Full Text] [Related]
15. Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival. Hill TD; Khamis HJ; Tyczynski JE; Berkel HJ Ann Epidemiol; 2005 Nov; 15(10):773-80. PubMed ID: 16257362 [TBL] [Abstract][Full Text] [Related]
16. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer. Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy. Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of the 2002 TNM classification for breast carcinoma with regard to the number of metastatic axillary lymph nodes. Duraker N; Caynak ZC Cancer; 2005 Aug; 104(4):700-7. PubMed ID: 16003773 [TBL] [Abstract][Full Text] [Related]
19. Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy. Lin YC; Chen SC; Chang HK; Hsueh S; Tsai CS; Lo YF; Hwang TL; Chen MF Jpn J Clin Oncol; 2005 Sep; 35(9):514-9. PubMed ID: 16199422 [TBL] [Abstract][Full Text] [Related]
20. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma. Di Saverio S; Gutierrez J; Avisar E Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]